Nabriva Therapeutics plc (NBRV) Q4 2021 Results Earnings Conference Call March 29, 2022 4:30 PM ET
Company Participants
Dan Dolan - Chief Financial Officer
Ted Schroeder - Chief Executive Officer
Steve Gelone - President and Chief Operating Officer
Conference Call Participants
Carl Byrnes - Northland Capital
Operator
Good day, and welcome to the Nabriva Therapeutics Fourth Quarter 2021 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, this call may be recorded.
I would like to turn the call over to Dan Dolan, Nabriva's Chief Financial Officer. You may begin.
Dan Dolan
Thank you. And good afternoon, everyone. Welcome to the Nabriva's conference call and webcast where we will be discussing the fourth quarter 2021 earnings and providing a business update. The slides for today's presentation are posted on the company's website, www.nabriva.com, and can be found under the Investors tab in the Events and Presentations section. We recommend that you refer to the presentation as we'll be using those slides for today's discussion.
Before we begin, on slide 2, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We will undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our most recent filings on Form 10-K and our
- Read more current NBRVF analysis and news
- View all earnings call transcripts